Underdosing of local antifung/infect/inflamm drugs, subs

This code signifies that a patient has received an insufficient amount of a topical medication that combines antifungal, anti-infective, and anti-inflammatory properties. This underdosing has occurred during a follow-up visit or during the healing phase of the condition, rather than the initial treatment. The inadequate dosage may have contributed to persistent symptoms or a lack of improvement.

Apply this code when documentation indicates that a patient's local antifungal, anti-infective, and anti-inflammatory medication was administered in a dose lower than prescribed or therapeutically effective, and this is being addressed during a subsequent encounter. This is appropriate for situations where the patient is returning for ongoing management of the condition, and the underdosing is identified as a factor in the treatment's efficacy.

• Ensure the documentation clearly specifies "underdosing" and that the medication is a local antifungal, anti-infective, and anti-inflammatory combination.
• The 7th character "D" is crucial, indicating a subsequent encounter for ongoing care related to the underdosing.
• Always code the specific adverse effect or condition resulting from the underdosing first, if applicable.